Results 191 to 200 of about 29,800 (242)

Treatment of Tislelizumab-Induced Toxic Epidermal Necrolysis and Agranulocytosis: A Case Report and Literature Review.

open access: yesCurr Drug Saf
Zhou Y   +8 more
europepmc   +1 more source

Toxic Epidermal Necrolysis

International Journal of Dermatology, 1991
Abstract Background. Most studies on drug‐induced toxic epidermal necrolysis (TEN) report a high mortality rate. This has been attributed partly to the use of corticosteroids for its treatment. However, we consider corticosteroids to be the sheet anchor for saving the patients having TEN. Materials and Methods.
Jagjit S. Pasricha   +4 more
  +11 more sources

Toxic Epidermal Necrolysis

Postgraduate Medicine, 1972
Toxic epidermal necrolysis, although uncommon, warrants the attention of all clinicians because of its serious prognosis. The clinical course of this cutaneous syndrome is similar in children and adults, but some differences do exist. Because diagnostic laboratory tests are not available, the physician must recognize the disorder by its distinctive ...
Arthur J. Ammann   +2 more
  +10 more sources

Home - About - Disclaimer - Privacy